Workflow
How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock

Core Viewpoint - Bristol-Myers Squibb Co. is expected to report a decline in Q3 2025 earnings, with analysts projecting an EPS of $1.67 and quarterly revenue of $11.76 billion, indicating a decrease from the previous year [2] Financial Performance - The company reported Q2 2025 earnings with an adjusted EPS of $1.46, which was below the consensus estimate of $1.58, while revenues of $12.30 billion exceeded the consensus of $11.31 billion [3] - Bristol-Myers Squibb's dividend yield stands at 5.37%, with a total dividend payout of $2.48 per share over the last 12 months [2] Future Guidance - The company has raised its full-year 2025 revenue guidance from approximately $45.8 billion to $46.8 billion to a new range of $46.5 billion to $47.5 billion [4] - CEO Christopher Boerner emphasized the focus on advancing transformational medicines and optimizing the company's cost structure to support long-term growth [4]